Malini Bajpai
Malini Bajpai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Abhijit Ray
1 shared publication- Abhijit Ray
Department of Pharmacology, Ranbaxy Research Laboratories, Plot No.20, Sector 18, Udyog Vihar Industrial Area, Gurgaon-122001 (Haryana), India
1 shared publication - Kamna Nanda
Department of Pharmacology, Ranbaxy Research laboratories, Gurgaon, Haryana, India
1 shared publication Mou Chatterjee
1 shared publicationPh D
Department of Pharmacology, New Drug Discovery Research, Ranbaxy Research Laboratories, Plot No-20, Sector-18, Gurgaon-122001-Haryana, India +91 124 2342001 10, ext: 5256; +91 124 2343544
1 shared publicationPuneet Chopra
1 shared publication
Latest Publications
- 1 September 2008
- Published by Elsevier in Analytical Biochemistry
- Vol. 380 (1) , 143-145
An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors
- 1 September 2008
- Published by Elsevier in Analytical Biochemistry
- Vol. 380 (1) , 143-145
An improved zinc cocktail-mediated fluorescence polarization-based kinase assay for high-throughput screening of kinase inhibitors
- 30 April 2008
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 17 (5) , 641-659
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
(2008). Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis. Expert Opinion on Investigational Drugs: Vol. 17, No. 5, pp. 641-659. doi: 10.1517/13543784.17.5.641
- 30 April 2008
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 17 (5) , 641-659
Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis
(2008). Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis. Expert Opinion on Investigational Drugs: Vol. 17, No. 5, pp. 641-659. doi: 10.1517/13543784.17.5.641